Clinical Trial

Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity.

Name: Development of a Pharmacogenomic Panel for Early Detection of Chemotherapy- and Immunotherapy-Induced Cardiotoxicity. — clinical trial record (NCT07663357)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the use of a pharmacogenetic and pharmacoepigenetic panel for predicting chemotherapy- and immunotherapy-induced cardiotoxicity in cancer patients.

Trial Details

NCT Number	NCT07663357
Lead Sponsor	Beneficência Portuguesa de São Paulo
Conditions	Cardiotoxicity
Enrollment	1,000 participants
Start Date	2026-05-11
Primary Completion	2029-03-01 (estimated)
Study Completion	2029-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-23